Position in CELC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$493,492
-$44,906 QoQ
Shares Held
4,717
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#171
of 273 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $6,186,234 across 23 Biotechnology names. CELC ranks #3 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,415 | $702,872 | |
| 2 | ALMS |
Alumis Inc.
|
23,599 | $664,075 | |
| 3 | CELC |
Celcuity Inc.
This page
|
4,717 | $493,492 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
709 | $442,089 | |
| 5 | VNDA |
Vanda Pharmaceuticals Inc.
|
63,878 | $390,933 | |
| 6 | RPRX |
Royalty Pharma plc
|
6,772 | $379,706 | |
| 7 | INCY |
Incyte Corp
|
2,879 | $326,363 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
866 | $289,928 |
All Filings in CELC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,492 | 4,717 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $538,398 | 4,717 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $470,473 | 4,717 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $231,290 | 4,682 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||